Cryptochlorogenic acid,
905-99-7,
4-Caffeoylquinic acid,
4-O-Caffeoylquinic acid,
UNII-F23DJ84IZ9,
4-O-trans-caffeoylquinic acid,
F23DJ84IZ9,
MFCD10566638,
4-(3,4-Dihydroxycinnamoyl)quinic acid,
4-O-(3,4-Dihydroxycinnamoyl)-D-quinic acid,
Quinic acid 4-O-caffeate,
Cryptochlorogenic-acid,
4-o-Caffeoyl quinic acid,
4-Cqa,
Quinic acid, 4-caffeoyl-,
4-O-(E)-caffeoylquinic acid,
CHEMBL3092676,
Cinnamic acid, 3,4-dihydroxy-, 4-carboxy-2,4,6-trihydroxycyclohexyl ester,
Quinic acid, 4-caffeoyl-, E-,
SCHEMBL18180782,
ACon1_000120,
CHEBI:75491,
HY-N0787,
CC0178,
ZINC31154929,
4-O-Caffeoylquinic acid, >=98.0%,
AKOS037514601,
ZINC100038257,
ZINC103240311,
CS-3767,
MCULE-7852282089,
NCGC00180861-01,
(1alpha,3alpha,4alpha,5beta)-4-(3-(3,4-(Dihydroxyphenyl)-1-oxo-2-propenyl)oxy)-1,3,5-trihydroxycyclohexanecarboxylic acid,
AK199152,
AN-47941,
Cryptochlorogenic acid, analytical standard,
N1745,
X1114,
A12036,
905C997,
Q-100886,
B0B55D52-5101-4E6D-AA67-72D1CECBAA5A,
49B68A4C-6EC9-4441-B7D7-E3B740A8CDEC,
(1S,3R,4S,5R)-4-{[(2E)-3-(3,4-dihydroxyphenyl)prop-2-enoyl]oxy}-1,3,5-trihydroxycyclohexanecarboxylic acid,
(3R,5R)-4-[(E)-3-(3,4-dihydroxyphenyl)prop-2-enoyl]oxy-1,3,5-trihydroxy-cyclohexanecarboxylic acid,
(3R,5R)-4-[(E)-3-(3,4-dihydroxyphenyl)prop-2-enoyl]oxy-1,3,5-trihydroxycyclohexane-1-carboxylic acid,
1,3beta,5alpha-Trihydroxy-4alpha-(3,4-dihydroxycinnamoyloxy)cyclohexane-1beta-carboxylic acid,
87099-73-8,
Cyclohexanecarboxylic acid, 4-(((2E)-3-(3,4-dihydroxyphenyl)-1-oxo-2-propen-1-yl)oxy)-1,3,5-trihydroxy-, (1alpha,3R,4alpha,5R)-,
Cyclohexanecarboxylic acid, 4-((3-(3,4-dihydroxyphenyl)-1-oxo-2-1R-propenyl)oxy)-1,3,5-trihydroxy-, (1R-(1alpha,3alpha,4alpha,5beta))-,
Cyclohexanecarboxylic acid, 4-((3-(3,4-dihydroxyphenyl)-1-oxo-2-propen-1-yl)oxy)-1,3,5-trihydroxy-, (1alpha,3R,4alpha,5R)-,
Cyclohexanecarboxylic acid, 4-((3-(3,4-dihydroxyphenyl)-1-oxo-2-propenyl)oxy)-1,3,5-trihydroxy-, (1alpha,3R,4alpha,5R)-,
Cyclohexanecarboxylicacid, 4-[[3-(3,4-dihydroxyphenyl)-1-oxo-2-propen-1-yl]oxy]-1,3,5-trihydroxy-,(1a,3R,4a,5R)-,
NCGC00180861-02!(3R,5R)-4-[(E)-3-(3,4-dihydroxyphenyl)prop-2-enoyl]oxy-1,3,5-trihydroxycyclohexane-1-carboxylic acid,
Eprazinone 2HCl,
C16H18O9,
ACN-035746,
C16-H18-O9,
CID9798666,
B1745,
10402-53-6,
Cyclohexanecarboxylic acid, 4-(3-(3,4-(dihydroxyphenyl)-1-oxo-2-propenyl)oxy)-1,3,5-trihydroxy-, (1alpha,3alpha,4alpha,5beta)-,